Larimar Therapeutics, Inc. · NASDAQ:LRMR

Hamilton Thomas Edward bought 70,000 Larimar Therapeutics, Inc. shares (Form 4)

Traded Nov 12, 2026 · Filed Nov 12, 2026

On Nov 12, 2026, Hamilton Thomas Edward (Director) bought 70,000 Larimar Therapeutics, Inc. shares at US$2.67 for US$187K, leaving 70,000 shares. Filed Nov 12, 2026 (Form 4).

Bought
70,000 shares
Price
US$2.67
Value
US$187K
Holding after
70,000 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 12, 2026Common StockBuy70,000US$2.6770,000Indirect

Source

Download original · View original at SEC

Related